Grifols Community

BME:GRF Community

1 Narratives written by author
0 Comments on narratives written by author
34 Fair Values set on narratives written by author

AN

AnalystConsensusTarget

Consensus Narrative from 13 Analysts

Upcoming Biopharma Launches And Operational Efficiencies Will Drive Future Success

Key Takeaways Strong growth in the Biopharma business with operational efficiencies and product launches boosts revenue and net margins through diversification and global market expansion. Improved cash flow and strengthened balance sheet allow focus on strategic growth, reduce financial risks, and enhance earnings over time.

€16.03

FV

47.1% undervalued

6.80%

Revenue growth p.a.

0

0

23

5 days ago